DDInter531 DDInter1376
Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea.
Ozanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease. It was developed by Celgene (now acquired by Bristol-Myers Squibb) and was approved by the FDA on March 26, 2020.[L12573,L12582] The US approval was followed by the approval in Canada on October 2, 2020. In November 2021, ozanimod was also approved by the European Commission for the treatment of adults with relapsing remitting multiple sclerosis.[L39377,L39382] MS is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Inflammatory bowel disease also a chronic inflammatory condition and can cause persistent abdominal pain, diarrhea, bloody stools, and vomiting. In clinical trials, Ozanimod has been shown to be well-tolerated and has resulted in a higher decrease in the rate of MS relapses than with intramuscular [interferon beta-1a], a current standard in MS therapy. Studies involving patients with inflammatory bowel disease have also shown promising results.[A189318,A189342]
Dezocine {u} (Compound) resembles {v} (Compound) Levorphanol
Dezocine {u} (Compound) binds {v} (Gene) OPRK1
Dezocine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Trimethobenzamide
Dezocine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Levocetirizine
Dezocine {u} may lead to a major life threatening interaction when taken with {v} Iohexol
Dezocine {u} may lead to a major life threatening interaction when taken with {v} Bupropion
Dezocine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dextromethorphan
Dezocine (Compound) resembles Levorphanol (Compound)
Dezocine (Compound) binds OPRK1 (Gene)
Dezocine may cause a moderate interaction that could exacerbate diseases when taken with Trimethobenzamide
Dezocine may cause a moderate interaction that could exacerbate diseases when taken with Levocetirizine
Dezocine may lead to a major life threatening interaction when taken with Iohexol
Dezocine may lead to a major life threatening interaction when taken with Bupropion
Dezocine (Compound) resembles Dextromethorphan (Compound) and Dezocine may cause a moderate interaction that could exacerbate diseases when taken with Dextromethorphan